Latest filing published 19 Jul 2022 for Insight Molecular Diagnostics Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -80.1%Entry US$26.80 · Close at T+365 US$5.34
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cavan M. Redmond: trading record in brief
Cavan M. Redmond is a declared insider at 4 companies (board member); the most frequent names are Wyeth, Pfizer Inc and Insight Molecular Diagnostics Inc. Over a trading history stretching from 23 January 2008 to 24 June 2022, the count stands at 20 filings.
The open-market record is one-sided, with 2 purchases worth €43k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 14 share grants and 1 option exercise. In 2022 alone, the filings show 1 purchase and no sales.
On 19 July 2022 came the latest disclosure, an option exercise in Insight Molecular Diagnostics Inc. The last purchase on record was published on 16 March 2022, which is 1,699 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cavan M. Redmond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0Common Stock, no par valueSEC:0001493152-22-019823:0
- 40,000 shares@ US$1.189100.0% of flowCommon Stock, no par valueSEC:0001493152-22-007054:0Canonical exit: 14 Jun 2022 (T+90)
- 18,416 sharesCommon StockSEC:0001493152-20-023588:0
- 52,447 sharesCommon stock, no par valueSEC:0001493152-18-010763:0Canonical exit: 24 Oct 2018 (T+90)
- 45,000 shares0Common StockSEC:0000947871-12-000514:0
- 21,206 shares0Common StockSEC:0001225208-12-005638:0
- 37,851 shares0Common StockSEC:0001225208-11-007689:0
- 22,284 shares0Common StockSEC:0001225208-10-006401:0
- 29,360 shares0Common StockSEC:0001225208-09-021562:0
- 17,616 shares0Common StockSEC:0001225208-09-021562:1
- 21,750 shares@ US$49.58Common StockSEC:0001209191-09-049119:0
- 14,353.83 sharesCommon StockSEC:0001209191-09-049119:1
- 31,177.43 sharesCommon Stock (Restricted Stock Trust)SEC:0001209191-09-049119:2
- 1,147 shares@ US$42.10Common StockSEC:0001209191-09-023212:0
- 6,800 shares0Common StockSEC:0001209191-09-013496:0
- 2,078 shares@ US$41.14Common StockSEC:0001209191-09-013496:1
- 1,147 shares@ US$44.93Common StockSEC:0001209191-08-025330:0
- 5,840 shares0Common StockSEC:0001209191-08-015764:0
- 1,785 shares@ US$42.54Common StockSEC:0001209191-08-015764:1
- 18,000 shares0Common StockSEC:0001209191-08-005741:0
20 of 20 declarations
